ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Novo tops Pfizer’s obesity bid; FDA moves to speed biosimilar approvals; Moderna–Merck rumors build — This Week in Biotech #76

Biotech Blueprint

31/10/2025 3 min

Listen "Novo tops Pfizer’s obesity bid; FDA moves to speed biosimilar approvals; Moderna–Merck rumors build — This Week in Biotech #76"

Descargar episodio Ver en sitio original

Episode Synopsis

Subscribe to Biotech Blueprint newsletter for free at biotechblueprint.com.

More episodes of the podcast Biotech Blueprint

CDC’s Autism Reversal Shocks Experts, mRNA Flu Shot Advances, Big Oncology Wins - This Week in Biotech #79 24/11/2025

FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78 14/11/2025

Inside Sensible Biotechnologies: Reinventing mRNA Manufacturing 13/11/2025

Trump Reshapes Obesity Drug Prices, Novo Tops Pfizer Again — This Week in Biotech #77 08/11/2025

Drug launch prices soar; mRNA shots linked to longer cancer survival — This Week in Biotech #75 26/10/2025

How mRNA Could Defeat Latent Viruses and Train Immunity Against Cancer 21/10/2025

Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74 19/10/2025

Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72 Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72 03/10/2025

ACIP votes, Roche-89bio deal, Regeneron’s FOP win — This Week in Biotech #70 19/09/2025

The mRNA Revolution: Beyond COVID to Cancer, Flu and Herpes Vaccines 18/09/2025

Ver todos los episodios